jazz pharma to bui gw pharma for $7.2 billion, ad cannabi-base drug to portfolio
(reuter) - jazz pharmaceut plc said on wednesdai it had agre to bui gw pharmaceut plc in a $7.2 billion cash-and-stock deal which will bolster it neurosci busi with the addit of a cannabi-base epilepsi treatment.
